Published on
Although rare, two of the most common congenital neck masses diagnosed during pregnancy are cervical teratomas and cervical lymphatic malformations. Learn about the delivery and treatment options of neck masses.
Published on
Newborns with a neck mass are cared for in CHOP's N/IICU by the Neonatal Surgical Team. Sclerotherapy is one of the treatment method used in babies with lymphatic malformations.
Published on
Congenital neck masses are now more often detected in utero due to high-resolution ultrasounds and fetal MRIs, which help differentiate the various types of neck masses.
Published on
The treatment of lymphatic malformations is complex and requires a multidisciplinary team, including pediatric interventional radiology. At CHOP, there are two pediatric interventional radiologists with a special interest in treating vascular malformations.
Published on
Just as prenatal imaging is imperative to establishing the diagnosis of fetal neck mass, genetic testing can be crucial to determining prognosis, availability of fetal interventions and recurrence risk for a family.
Published on
In March 2016, the Center for Fetal Diagnosis and Treatment attended the American Institute of Ultrasound in Medicine (AIUM) 2016 Annual Convention in New York City.
Published on
For 20 years, the Center for Fetal Diagnosis and Treatment has offered hope before birth. Today, the Center is the largest and most comprehensive program of its kind.
Published on
"TWICE BORN: Stories from the Special Delivery Unit," the gripping three-part series, aired by PBS in March 2015, shares the stories of four families with high-risk pregnancies who journey to The Children's Hospital of Philadelphia from across the country for help and hope not available elsewhere.
Published on
On Oct. 4, CHOP's Center for Fetal Diagnosis and Treatment hosted a reunion at the Cleveland Botanical Gardens for families across the Midwest who traveled to CHOP for fetal surgery or specialized care immediately after birth.
Published on
Despite advances in care, there remain high rates of morbidity and mortality in cases of severe CDH. Read about CHOP’s FDA-approved study of fetoscopic endoluminal tracheal occlusion (FETO).